BSECompany Update4d ago
Dolphin Medical Services Ltd
As attached
Dolphin Medical Services Ltd has submitted a Confirmation Certificate to the Bombay Stock Exchange (BSE) under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 30.06.2026.
BSEInsider Trading / SAST30 Sept 2026
Dolphin Medical Services Ltd
Closure of Trading Wndow
Dolphin Medical Services Ltd has announced the closure of its trading window for designated persons, including insiders, from October 1, 2026, until 48 hours after the announcement of its unaudited financial results for the second quarter ended September 30, 2026.
BSEBoard MeetingMgmt Change20 Sept 2026
Dolphin Medical Services Ltd
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to consider and approve To consider and approve the appointment of Mr. Amarandhar Reddy Kotha (DIN: 07425226) as Chairman and Promoter Director of the Company and other items
Dolphin Medical Services Ltd has scheduled a Board Meeting on 21/09/2026 to consider the appointment of Mr. Amarandhar Reddy Kotha as Chairman and Promoter Director, change of category of Mr. Rajesh Kumar Mallour, and reconstitution of Board Committees.
BSEGeneralMgmt Change12 Sept 2026
Dolphin Medical Services Ltd
Intimation of Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.
Dolphin Medical Services Ltd has announced the resignation of its Managing Director and CEO, Mr. G V MOHAN PRASAD, and two directors, LAKSHMI SUDHA MADALA and DWARAKANATH MADALA, with immediate effect.
BSECompany UpdateMgmt Change12 Sept 2026
Dolphin Medical Services Ltd
Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA
Dolphin Medical Services Ltd has announced the resignation of its Managing Director and CEO, Mr. G V MOHAN PRASAD, along with two other directors, LAKSHMI SUDHA MADALA and DWARAKANATH MADALA, with immediate effect.
BSECompany Update3 Sept 2026
Dolphin Medical Services Ltd
Intimation of Extension of AGM
Dolphin Medical Services Ltd has received approval from the Registrar of Companies, Telangana to extend the Annual General Meeting (AGM) by two months, up to November 30, 2026, due to unforeseen circumstances.
BSECompany UpdateFundraise28 Aug 2026
Dolphin Medical Services Ltd
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board ....
Dolphin Medical Services Ltd has received a post-offer advertisement from Rarever Financial Advisors Pvt Ltd regarding the open offer to acquire 26% of the company's equity shares at ₹4.80 per share.
BSEResultResults14 Aug 2026
Dolphin Medical Services Ltd
Results
Dolphin Medical Services Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at Rs. 20.60 lakhs, and net profit for the period at Rs. 1.78 lakhs. The company's earnings per equity share for continuing operations is Rs. 0.11.
BSEBoard MeetingResults14 Aug 2026
Dolphin Medical Services Ltd
Board meeting outcome
Dolphin Medical Services Ltd has submitted its unaudited financial results for the quarter ended June 30, 2026, with a net profit of Rs. 1.78 lakhs and basic earnings per share of Rs. 0.11.
BSEBoard MeetingResults9 Aug 2026
Dolphin Medical Services Ltd
Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....
Dolphin Medical Services Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026, inter alia, to consider and approve the unaudited standalone financial results of the Company for the 1st quarter ended June 30, 2026 of the Financial Year 2026-27.
BSECompany UpdateFundraise30 Jul 2026
Dolphin Medical Services Ltd
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement ....
Dolphin Medical Services Ltd has announced an open offer by Rarever Financial Advisors Pvt Ltd on behalf of Amarandhar Reddy Kotha and Mallour Rajesh Kumar to acquire 39,25,988 equity shares, representing 26% of the company's equity share capital and voting capital, at a price of ₹4.80 per share.
BSECompany UpdateBuyback29 Jul 2026
Dolphin Medical Services Ltd
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Recommendations of the Committee of Independent Directors (''IDC'') of Dolphin Medical Services ....
Dolphin Medical Services Ltd has received recommendations from the Committee of Independent Directors (''IDC'') regarding a buyback program.
BSECompany UpdateM&A27 Jul 2026
Dolphin Medical Services Ltd
Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").
Dolphin Medical Services Ltd has received a Letter of Offer from Rarever Financial Advisors Pvt Ltd on behalf of Amarandhar Reddy Kotha and Mallour Rajesh Kumar to acquire up to 39,25,988 equity shares, representing 26% of the company's voting capital, at ₹4.80 per share.
BSECompany Update▼ NegativeMgmt Change25 Jul 2026
Dolphin Medical Services Ltd
Ms. Vaishnavi Sharma, Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.
Dolphin Medical Services Ltd announced the resignation of its Chief Financial Officer (CFO) and Company Secretary, Vaishnavi Sharma, effective from July 24, 2026. The Board appreciated Sharma's services and disclosed the required information under Regulation 30 of the SEBI (LODR) Regulations, 2015.
BSECompany UpdateMgmt Change25 Jul 2026
Dolphin Medical Services Ltd
Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.
Dolphin Medical Services Ltd announced the resignation of its Company Secretary and Compliance Officer, Ms. Vaishnavi Sharma, effective July 24, 2026. The Board of Directors accepted her resignation and appreciated her valuable services during her tenure.